# TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)

> **NCT04526951** · PHASE3 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 81 (actual)

## Conditions studied

- Central Retinal Artery Occlusion

## Interventions

- **DRUG:** Intravenous injection of Tenecteplase and one dose of placebo tablet
- **DRUG:** One tablet of Acetylsalicylic Acid and one dose of IV placebo

## Key facts

- **NCT ID:** NCT04526951
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-30
- **Primary completion:** 2025-06-20
- **Final completion:** 2025-06-20
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04526951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04526951, "TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04526951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*